HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new weapon to boost cancer treatment
Disease control OngoingThis early-stage study is testing whether adding an experimental drug called berzosertib to standard chemotherapy (cisplatin) and radiation can better treat advanced head and neck cancer. The main goals are to find the safest and most effective dose of this new combination and to…
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo tested for Tough-to-Treat head and neck cancers
Disease control OngoingThis early safety study is testing a new oral drug called tolinapant given alongside standard radiation therapy. It is for patients with locally advanced head and neck cancer who cannot receive the usual chemotherapy drug, cisplatin. The main goal is to see if the combination is …
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 25, 2026 14:16 UTC